Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

2001 • 6,888 citations

Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis

2002 • 1,962 citations

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

1995 • 1,903 citations

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.

2001 • 697 citations

European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

2001 • 595 citations

Normalized Accurate Measurement of Longitudinal Brain Change

2001 • 490 citations

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

2001 • 215 citations

The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

2005 • 209 citations

Mechanism of action of mitoxantrone

2004 • 196 citations

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

2002 • 183 citations

Mechanisms of immunomodulation by glatiramer acetate

2000 • 161 citations

Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis

2004 • 120 citations

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor

2003 • 118 citations

Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS

2001 • 105 citations

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

2008 • 93 citations

Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis

2006 • 86 citations

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype

2003 • 46 citations

Glatiramer acetate for the treatment of multiple sclerosis

2004 • 34 citations